Overview
Smitha Mellacheruvu is a Hematologist Oncology specialist and a Hematologist in Poughkeepsie, New York. Dr. Mellacheruvu is rated as an Experienced provider by MediFind in the treatment of Pituitary Tumor. Her top areas of expertise are Intraductal Papilloma, Paget Disease of the Breast, Multiple Myeloma, and Prostate Cancer.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
45 Reade Pl, Fl 2, Poughkeepsie, NY 12601
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Lawrence Medical Associates PC
Anthony Provenzano is a Hematologist Oncology specialist and an Oncologist in Eastchester, New York. Dr. Provenzano is rated as an Advanced provider by MediFind in the treatment of Pituitary Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Paget Disease of the Breast, Breast Cancer, and Squamous Cell Lung Carcinoma.
Yale University
Sylvia Kurz is a Neurologist and a Palliative Medicine provider in New Haven, Connecticut. Dr. Kurz is rated as an Advanced provider by MediFind in the treatment of Pituitary Tumor. Her top areas of expertise are Neurofibromatosis Type 2 (NF2), Astrocytoma, Oligodendroglioma, and Brain Tumor.
HMH - John Theurer Cancer Center - Hackensack
Deric Park is a Neurologist and a Hematologist in Hackensack, New Jersey. Dr. Park is rated as a Distinguished provider by MediFind in the treatment of Pituitary Tumor. His top areas of expertise are Gliosarcoma, Astrocytoma, Brain Tumor, and Glioblastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Intraductal PapillomaDr. Mellacheruvu isDistinguished. Learn about Intraductal Papilloma.
- Advanced
- AnemiaDr. Mellacheruvu isAdvanced. Learn about Anemia.
- Breast CancerDr. Mellacheruvu isAdvanced. Learn about Breast Cancer.
- Deep Vein ThrombosisDr. Mellacheruvu isAdvanced. Learn about Deep Vein Thrombosis.
- Familial Prostate CancerDr. Mellacheruvu isAdvanced. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Mellacheruvu isAdvanced. Learn about Inflammatory Breast Cancer.
- Multiple MyelomaDr. Mellacheruvu isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Mellacheruvu isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Eosinophilic PneumoniaDr. Mellacheruvu isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Mellacheruvu isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Mellacheruvu isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Mellacheruvu isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Mellacheruvu isExperienced. Learn about Acute Myeloid Leukemia (AML).